Detection of early incomplete heparin reversal following congenital cardiac surgery: A single-center retrospective observational study
The monitoring of unfractionated heparin (UFH) reversal with protamine plays a crucial role for bleeding management after cardio-pulmonary bypass (CPB) in congenital cardiac surgery. The current standard for the monitoring of UFH and its reversal is the activated clotting time (ACT). While the ACT is affected by other CPB-associated pathologies a bedside technique with more specific heparin-related results would be very helpful. The new point-of-care viscoelastic test Haemonetics TEG ® 6s, which is based on small blood samples may fulfill these requirements.
Source: Thrombosis Research - Category: Hematology Authors: Harry Magunia, Sebastian Schenk, Christian Schlensak, Vanya Icheva, Peter Rosenberger, Andreas Straub, Martina Nowak-Machen Tags: Full Length Article Source Type: research
More News: Bleeding | Cardiology | Heart | Hematology | Pulmonary Thromboembolism | Study | Thrombosis